Post COVID-19 Functional Status in Egypt
NCT04479293 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2020-09-09
Summary
Since the outbreak of coronavirus disease - COVID-19 pandemic, most attention has focused on mode of transmission, clinical picture of the disease, treatment and prevention. In the coming weeks and months emphasis will gradually involve the post- acute care of COVID-19 survivors. It is anticipated that COVID-19 may have major impact on physical, cognitive, mental, social health status even in patients with mild disease. Moreover, pulmonary, radiologic, laboratory, sleep issues remain to be addressed
Conditions
- COVID-19
- Coronavirus Disease
- SARS-CoV-2
Interventions
- OTHER
-
Post COVID-19 Functional Satus Scale
scale from 0-64 assessing functional limitation
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Aliae Mohamed-Hussein, MD · Assiut University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-07-01
- Primary Completion
- 2020-10-30
- Completion
- 2020-11-30
Countries
- Egypt
Study Locations
More Related Trials
-
Metabolic Features Effects on FAST Score in MASLD Patients
NCT06867419 ·Status: RECRUITING
-
MAFLD Fibrosis Score for Detecting Fibrotic NASH in MAFLD Egyptian Patients
NCT06492369 ·Status: COMPLETED
-
Metabolic Syndrome and Fatty Liver Disease Among Egyptian Patients with Chronic HBV
NCT06589167 ·Status: NOT_YET_RECRUITING
-
Prevalence of NAFLD and Correlation With Its Main Risk Factors Among Egyptian
NCT04081571 ·Status: UNKNOWN
-
Role of Regulatory B Cells in the Pathogenesis of Metabolic Associated Fatty Liver Disease
NCT04720560 ·Status: RECRUITING
-
COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study
NCT04329559 ·Status: COMPLETED
-
Assessment of Nonalcoholic Fatty Liver Disease in Diabetic and Prediabetic Patients Using Noninvasive Methods.
NCT04553796 ·Status: UNKNOWN
-
Fetuin-A, a Promising Serum Biomarker for Diagnosis of Non-Alcoholic Fatty Liver Disease
NCT06097039 ·Status: COMPLETED
-
Screening for Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD) at Al-Rajhy Hospital Nutrition Clinic. Assiut, Egypt
NCT04861012 ·Status: UNKNOWN ·Phase: NA
-
Metabolic Syndrome and Long-term Survival Following Liver Resection
NCT05568576 ·Status: COMPLETED
-
Health Related Quality of Life Assessment In Egyptian Recipients After Living Donor Liver Transplantation
NCT01784497 ·Status: COMPLETED
-
Study Of Bacterial/Fungal Infections in Hospitalized Patients With Liver Cirrhosis in China
NCT03676777 ·Status: UNKNOWN
-
The Commonest Medical, Surgical, and Oncological Causes of Acute Abdomen in Adults With COVID-19. A Prospective Observational Study.
NCT05295251 ·Status: COMPLETED
-
Evaluation of Non-B Non-C Liver Cirrhosis in A EL-Rajhi Assuit University Hospital: A Retrospective-Prospective Study
NCT05314270 ·Status: UNKNOWN
-
Pulmonary Function Tests Study in Cirrhotic Patients With and Without Hepatocellular Carcinoma
NCT05963776 ·Status: UNKNOWN
-
Evaluation of Liver Fibrosis in HIV-infected Patients With Metabolic Syndrome
NCT02353767 ·Status: COMPLETED
-
Omics-based Predictors of NAFLD/Potential NASH
NCT05301231 ·Status: UNKNOWN
-
Plasma MicroRNA for Prediction of Hepatocellular Carcinoma
NCT05449847 ·Status: COMPLETED
-
Thyroid Function in Liver Cirrhosis: Is it Affected?
NCT05250401 ·Status: COMPLETED
-
Evaluation of Patients With Liver Disease
NCT00001971 ·Status: RECRUITING
-
Association of Hepatitis C Virus With Breast Cancer
NCT04090164 ·Status: COMPLETED
-
Non-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology Consultation
NCT04782050 ·Status: COMPLETED ·Phase: NA
-
AI Models vs Non-Invasive Fibrosis Scores in MAFLD Diagnosis
NCT07305636 ·Status: COMPLETED
-
Prevalance of non_ Alcoholic Fatty Liver Diseases in Patient With Inflammatory Bowel Diseases Attending Assiut University Hospitals
NCT04328259 ·Status: UNKNOWN
-
COVID19-FOIE National Observatory
NCT04375670 ·Status: COMPLETED